SRAX, Inc. · OTC:SRAX

SRAX — SRAX Investor Conference March 2023

16 slides from SRAX's conference presentation, Mar 15, 2023

  1. Slide 1: Investors March 2023

    SRAZF Investors March 2023

  2. Slide 2: Safe Harbor Statement

    Safe Harbor Statement: This presentation contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Words or expressions such as "anticipate," "plan,

  3. Slide 3: Apology and actions following NASDAQ delisting

    I want to start by offering my sincere apologies for the recent events that led to our company being delisted from NASDAQ. We understand that this has caused significant concern and disappointment among our shareholders, and we take full responsibility for the situation. We want you to know that we

  4. Slide 4: Table of Contents

    01 05 Introduction Overview of the LD Micro Transaction 02 What led to the issue 06 Table of The current state of the business Contents 03 What are we doing to fix our 07 accounting problem Conclusion 04 Overview of the DNA Transaction

  5. Slide 5: History of the Issue

    History of the Issue We were unable to file our quarterly reports on form 10-Q for June 30, 2022 and September 30,2022 by nasdaq’s Feb 28, 2023 deadline, consequently, on March 7, 2023, the Company received written notice from the Panel stating that they have determined to suspend trading of the Com

  6. Slide 6: Efforts to Resolve the Accounting Issue

    Efforts to Resolve the Accounting Issue: To address the issues underlying our inability to file our SEC reports in a timely manner, we have taken steps to bring in a new CFO. He has been working closely with our team as a consultant for the past six weeks to gain a better understanding of the compan

  7. Slide 7: Alan Urban CFO

    Alan Urban CFO We are excited to introduce Alan Urban, who brings over 30 years of corporate finance and accounting experience to our team. Alan has extensive public accounting experience and holds a CPA license (currently inactive). He has served as the CFO of Research Solutions (Nasdaq: RSSS) for

  8. Slide 8: Alan Urban CFO experience

    Alan Urban CFO 30 years 30 years of corporate Public accounting CFO of Research Solutions finance and accounting experience, CPA (inactive) (Nasdaq:RSSS) for 10 years, experience CFO of ReachLocal (Nasdaq:RLOC) SaaS experience Microcap experience Finance and accounting department buildout experience

  9. Slide 9: Priorities

    Priorities 01 02 03 04 05 Get current on SEC Buildout staff, Ensure management Focus on SaaS Focus on cash flow , filings systems, and has the information metrics, margins and Focus on value they need in a timely processes to ensure profitability creation planning manner to make we never become info

  10. Slide 10: Overview of DNA Transaction

    Overview of DNA Transaction We have not had the chance to talk to you all about the DNA transaction. DNA has generated over $50 million in investment returns over the past five years for its team. Our relationship with DNA dates back to 2018, and we are proud to collaborate with a company that prima

  11. Slide 11: What this Deal Looks Like

    What this Deal Looks Like Our relationship with DNA dates back to 2018. DNA primarily focuses on helping private technology companies position themselves, develop marketing materials, and gain exposure to early-stage investors, similar to what SRAX does for public companies. DNA’s fully commission-b

  12. Slide 12: Sale of LD Micro subsidiary to Freedom Holdings

    We are pleased to announce the sale of our LD Micro subsidiary to Freedom Holdings for $8.3 million, consisting of $4 million in cash and $4.3 million in Freedom Holdings stock. Under the terms of the agreement, SRAX has the ability to sell the stock in six months from the date of the transaction, o

  13. Slide 13: Current Focus on Cashflow and Operations

    Current Focus on Cashflow and Operations We received $4 million of cash from the LD transaction, approximately $2M was used to pay liabilities, including $400K to reduce our debt, and approximately $2M remains in our accounts. Currently we are focusing on cashflow, SaaS metrics, gross margins and pr

  14. Slide 14: Q&A

    Q&A SRAZF

  15. Slide 15: Slide 15

  16. Slide 16: Thank you

    Thank you SRAZ

SRAX — SRAX Investor Conference March 2023 on 6ix